BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 29079726)

  • 1. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
    Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
    Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant HMGB1 A box protein inhibits Th17 responses in mice with neutrophilic asthma by suppressing dendritic cell-mediated Th17 polarization.
    Zhang F; Huang G; Hu B; Qian GS; Song Y
    Int Immunopharmacol; 2015 Jan; 24(1):110-8. PubMed ID: 25479722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HMGB1 neutralizing antibody ameliorates neutrophilic airway inflammation by suppressing dendritic cell-mediated Th17 polarization.
    Zhang F; Huang G; Hu B; Fang LP; Cao EH; Xin XF; Song Y; Shi Y
    Mediators Inflamm; 2014; 2014():257930. PubMed ID: 24959003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 regulates T helper 2 and T helper17 cell differentiation both directly and indirectly in asthmatic mice.
    Li R; Wang J; Zhu F; Li R; Liu B; Xu W; He G; Cao H; Wang Y; Yang J
    Mol Immunol; 2018 May; 97():45-55. PubMed ID: 29567318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
    Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
    J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sRAGE Inhibits the Mucus Hypersecretion in a Mouse Model with Neutrophilic Asthma.
    Zhang X; Xie J; Sun H; Wei Q; Nong G
    Immunol Invest; 2022 Jul; 51(5):1243-1256. PubMed ID: 34018452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP/P2X7-NLRP3 axis of dendritic cells participates in the regulation of airway inflammation and hyper-responsiveness in asthma by mediating HMGB1 expression and secretion.
    Li R; Wang J; Li R; Zhu F; Xu W; Zha G; He G; Cao H; Wang Y; Yang J
    Exp Cell Res; 2018 May; 366(1):1-15. PubMed ID: 29545090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α-induced protein 3 levels in lung dendritic cells instruct T
    Vroman H; Bergen IM; van Hulst JAC; van Nimwegen M; van Uden D; Schuijs MJ; Pillai SY; van Loo G; Hammad H; Lambrecht BN; Hendriks RW; Kool M
    J Allergy Clin Immunol; 2018 May; 141(5):1620-1633.e12. PubMed ID: 28888782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble RAGE is deficient in neutrophilic asthma and COPD.
    Sukkar MB; Wood LG; Tooze M; Simpson JL; McDonald VM; Gibson PG; Wark PA
    Eur Respir J; 2012 Mar; 39(3):721-9. PubMed ID: 21920897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.
    Lu HY; Ma JL; Shan JY; Zhang J; Wang QX; Zhang Q
    World J Pediatr; 2017 Jun; 13(3):228-235. PubMed ID: 27995540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury.
    Izushi Y; Teshigawara K; Liu K; Wang D; Wake H; Takata K; Yoshino T; Takahashi HK; Mori S; Nishibori M
    J Pharmacol Sci; 2016 Apr; 130(4):226-34. PubMed ID: 27038888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of epigallocatechin-3-gallate on the HMGB1/RAGE pathway in PM
    Li Y; Chen L; Guo F; Cao Y; Hu W; Shi Y; Lin X; Hou J; Li L; Ding X; Guo Y
    Biochem Biophys Res Commun; 2019 Jun; 513(4):898-903. PubMed ID: 31003767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells.
    Tae YM; Park HT; Moon HG; Kim YS; Jeon SG; Roh TY; Bae YS; Gho YS; Ryu SH; Kwon HS; Kim YK
    J Immunol; 2012 Feb; 188(4):1799-808. PubMed ID: 22262660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma.
    Lee CC; Lai YT; Chang HT; Liao JW; Shyu WC; Li CY; Wang CN
    Biochem Pharmacol; 2013 Oct; 86(7):940-9. PubMed ID: 23948063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of IL-6 in dendritic cell-induced allergic inflammation of asthma.
    Lin YL; Chen SH; Wang JY
    J Mol Med (Berl); 2016 Jan; 94(1):51-9. PubMed ID: 26232935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
    Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
    J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.
    Abe H; Okada-Tsuchioka M; Kajitani N; Omori W; Itagaki K; Shibasaki C; Boku S; Matsuhisa T; Takebayashi M
    Neuropsychopharmacol Rep; 2023 Sep; 43(3):359-364. PubMed ID: 37337402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulforaphane treatment reverses corticosteroid resistance in a mixed granulocytic mouse model of asthma by upregulation of antioxidants and attenuation of Th17 immune responses in the airways.
    Al-Harbi NO; Nadeem A; Ahmad SF; AlThagfan SS; Alqinyah M; Alqahtani F; Ibrahim KE; Al-Harbi MM
    Eur J Pharmacol; 2019 Jul; 855():276-284. PubMed ID: 31100413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
    Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of RAGE and HMGB1 in inflammatory heart disease.
    Bangert A; Andrassy M; Müller AM; Bockstahler M; Fischer A; Volz CH; Leib C; Göser S; Korkmaz-Icöz S; Zittrich S; Jungmann A; Lasitschka F; Pfitzer G; Müller OJ; Katus HA; Kaya Z
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E155-64. PubMed ID: 26715748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.